Cargando…
CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039051/ https://www.ncbi.nlm.nih.gov/pubmed/36964132 http://dx.doi.org/10.1038/s41408-023-00813-x |
| _version_ | 1784912198854770688 |
|---|---|
| author | Niu, Jiahua Qiu, Huiying Xiang, Fang Zhu, Lin Yang, Jun Huang, Chongmei Zhou, Kun Tong, Yin Cai, Yu Dong, Baoxia Lu, Yuan Sun, Xuedong Wan, Liping Ding, Xueying Wang, Haopeng Song, Xianmin |
| author_facet | Niu, Jiahua Qiu, Huiying Xiang, Fang Zhu, Lin Yang, Jun Huang, Chongmei Zhou, Kun Tong, Yin Cai, Yu Dong, Baoxia Lu, Yuan Sun, Xuedong Wan, Liping Ding, Xueying Wang, Haopeng Song, Xianmin |
| author_sort | Niu, Jiahua |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10039051 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100390512023-03-26 CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study Niu, Jiahua Qiu, Huiying Xiang, Fang Zhu, Lin Yang, Jun Huang, Chongmei Zhou, Kun Tong, Yin Cai, Yu Dong, Baoxia Lu, Yuan Sun, Xuedong Wan, Liping Ding, Xueying Wang, Haopeng Song, Xianmin Blood Cancer J Correspondence Nature Publishing Group UK 2023-03-24 /pmc/articles/PMC10039051/ /pubmed/36964132 http://dx.doi.org/10.1038/s41408-023-00813-x Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Niu, Jiahua Qiu, Huiying Xiang, Fang Zhu, Lin Yang, Jun Huang, Chongmei Zhou, Kun Tong, Yin Cai, Yu Dong, Baoxia Lu, Yuan Sun, Xuedong Wan, Liping Ding, Xueying Wang, Haopeng Song, Xianmin CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study |
| title | CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study |
| title_full | CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study |
| title_fullStr | CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study |
| title_full_unstemmed | CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study |
| title_short | CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study |
| title_sort | cd19/cd22 bispecific car-t cells for mrd-positive adult b cell acute lymphoblastic leukemia: a phase i clinical study |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039051/ https://www.ncbi.nlm.nih.gov/pubmed/36964132 http://dx.doi.org/10.1038/s41408-023-00813-x |
| work_keys_str_mv | AT niujiahua cd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT qiuhuiying cd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT xiangfang cd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT zhulin cd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT yangjun cd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT huangchongmei cd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT zhoukun cd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT tongyin cd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT caiyu cd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT dongbaoxia cd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT luyuan cd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT sunxuedong cd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT wanliping cd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT dingxueying cd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT wanghaopeng cd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT songxianmin cd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy |